Announcements

Job offersmore »

Tweeting Growers

Top 5 - yesterday

Top 5 - last week

Top 5 - last month

Exchange ratesmore »




Monsanto signs genome-editing licensing agreement with Broad Institute

Monsanto Company has reached a new global licensing agreement with the Broad Institute of MIT and Harvard for the use of the novel CRISPR-Cpf1 genome-editing technology in agriculture. The CRISPR-Cpf1 system has potential to be a simpler and more precise tool for making targeted improvements in a cell's DNA when compared to the CRISPR-Cas9 system.

Researchers believe that the CRISPR-Cpf1 system may offer an expanded set of benefits for advancing and delivering improved agricultural products than the CRISPR-Cas9 system. Some of these benefits include greater flexibility in the method used to edit and in the locations where edits may occur. In addition, the smaller size of the CRISPR-Cpf1 system provides researchers with more flexibility to use the genome-editing technology across multiple crops.

“The CRISPR-Cpf1 system is a powerful new discovery within the field of genome editing, and we’re excited to license the system and add it to our growing portfolio of genome-editing tools,” said Tom Adams, Ph.D., biotechnology lead for Monsanto. “This system offers a technical step-change by presenting new ways to improve crops for farmers and society alike, offering researchers greater flexibility and new capabilities using this emerging technology to improve agriculture.”

“The CRISPR-Cpf1 system represents a transformative application of genome editing for the research community,” said Issi Rozen, chief business officer of the Broad Institute. “This system can directly benefit advanced research in human health and global agriculture. We are proud to partner with stakeholders throughout the biomedical and agriculture community to help deliver responsible solutions for our planet.”

Monsanto believes that genome-editing technologies – including the CRISPR-Cpf1 system – will continue to provide a powerful tool for its research in plant breeding and biotechnology, with the promise to unlock the full potential of its world-leading germplasm and genome libraries and contribute to the development of exciting new products. The company is exploring genome editing in a phased approach across single-gene knock-outs, single-gene edits and multiple-gene edits. Over the last year, Monsanto has licensed multiple genome-editing technologies – including a separate license from the Broad Institute for use of the CRISPR-Cas9 system in agriculture – to develop a leading portfolio of tools in this field. The intellectual property around the CRISPR-Cpf1 system is independent from the CRISPR-Cas patent estate, and this CRISPR-Cpf1 license provides Monsanto with another valuable tool for genome editing in this rapidly advancing field of science.

Under the agreement, the Broad Institute grants Monsanto a worldwide non-exclusive license for agricultural applications of the CRISPR-Cpf1 system. Additional terms of the agreement were not disclosed.

For more information:
www.broadinstitute.org
monsanto.com

Publication date: 1/6/2017

 


 

Other news in this sector:

9/19/2017 RNA discovery could help boost plant heat, drought tolerance
9/19/2017 UC Davis settles strawberry breeding lawsuit
9/18/2017 A closer look at element defects in peppers
9/18/2017 NL: Summer School Green Genetics #SSGG17
9/14/2017 US (WI): Farm to Flavor dinner showcases vegetables bred for flavor
9/14/2017 ESA launches new communication initiative
9/14/2017 US (AR): $2.45 million USDA grant for spinach research
9/11/2017 Tasty innovation combines eggplants with look of tomatoes
9/8/2017 US (WV): WVU announces names of 150th-anniversary tomato varieties
9/6/2017 Rijk Zwaan presents new lettuce type for Asian market
9/5/2017 How plants turn off genes they don’t need
9/1/2017 A closer look at differential influences of leaf tip trimming in tomatoes
8/30/2017 "The number of varieties in Romaine lettuce is growing quickly"
8/30/2017 New tech simplifies DNA sequencing for primary sector
8/30/2017 UK: Blueberry breeding consortium launched in Dundee
8/28/2017 Australia: Trail of 13 million year old gene transfer uncovered
8/28/2017 Monsanto and ToolGen reach licensing agreement on CRISPR platform
8/28/2017 US (CA): $4.5 million grant funds new disease-resistant strawberries
8/25/2017 US: NIFA invests $35 million in specialty crop research
8/25/2017 US: Deadline approaches for plant science student video contest